Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Failure modes and effects analysis for testicular sperm extraction management process.

Canepa P, De Leo C, Casciano I, Rizzo C, Sozzi F, Ambrosini F, Terrone C, De Rose AF, Anserini P, Scaruffi P.

Andrologia. 2020 Jan 8:e13506. doi: 10.1111/and.13506. [Epub ahead of print]

PMID:
31912917
2.

Gonadotropin Releasing Hormone Agonists Have an Anti-apoptotic Effect on Cumulus Cells.

Scaruffi P, Stigliani S, Cardinali B, Massarotti C, Lambertini M, Sozzi F, Dellepiane C, Merlo DF, Anserini P, Mastro LD.

Int J Mol Sci. 2019 Nov 30;20(23). pii: E6045. doi: 10.3390/ijms20236045.

3.

Beyond fertility preservation: role of the oncofertility unit in the reproductive and gynecological follow-up of young cancer patients.

Massarotti C, Scaruffi P, Lambertini M, Sozzi F, Remorgida V, Anserini P.

Hum Reprod. 2019 Aug 1;34(8):1462-1469. doi: 10.1093/humrep/dez108.

PMID:
31339999
4.

Non-invasive mitochondrial DNA quantification on Day 3 predicts blastocyst development: a prospective, blinded, multi-centric study.

Stigliani S, Orlando G, Massarotti C, Casciano I, Bovis F, Anserini P, Ubaldi FM, Remorgida V, Rienzi L, Scaruffi P.

Mol Hum Reprod. 2019 Sep 1;25(9):527-537. doi: 10.1093/molehr/gaz032.

PMID:
31174207
5.

Impact of infertility and infertility treatments on quality of life and levels of anxiety and depression in women undergoing in vitro fertilization.

Massarotti C, Gentile G, Ferreccio C, Scaruffi P, Remorgida V, Anserini P.

Gynecol Endocrinol. 2019 Jun;35(6):485-489. doi: 10.1080/09513590.2018.1540575. Epub 2019 Jan 7.

PMID:
30612477
6.

Combined treatment with myo-inositol, alpha-lipoic acid, folic acid and vitamins significantly improves sperm parameters of sub-fertile men: a multi-centric study.

Canepa P, Dal Lago A, De Leo C, Gallo M, Rizzo C, Licata E, Anserini P, Rago R, Scaruffi P.

Eur Rev Med Pharmacol Sci. 2018 Oct;22(20):7078-7085. doi: 10.26355/eurrev_201810_16180.

7.

A successful healthy childbirth and an ongoing evolutive pregnancy in a case of partial globozoospermia by hyaluronic acid sperm selection.

Canepa P, Casciano I, De Leo C, Massarotti C, Anserini P, Remorgida V, Scaruffi P.

Andrologia. 2019 Mar;51(2):e13178. doi: 10.1111/and.13178. Epub 2018 Oct 15.

PMID:
30324675
8.

miRNA expression profile of bone marrow resident cells from children with neuroblastoma is not significantly different from that of healthy children.

Stigliani S, Morandi F, Persico L, Lagazio C, Erminio G, Scaruffi P, Corrias MV.

Oncotarget. 2018 Apr 10;9(27):19014-19025. doi: 10.18632/oncotarget.24874. eCollection 2018 Apr 10.

9.

Presence of aggregates of smooth endoplasmic reticulum in MII oocytes affects oocyte competence: molecular-based evidence.

Stigliani S, Moretti S, Casciano I, Canepa P, Remorgida V, Anserini P, Scaruffi P.

Mol Hum Reprod. 2018 Jun 1;24(6):310-317. doi: 10.1093/molehr/gay018.

PMID:
29635518
10.

Altered erythropoiesis and decreased number of erythrocytes in children with neuroblastoma.

Morandi F, Barco S, Stigliani S, Croce M, Persico L, Lagazio C, Scuderi F, Belli ML, Montera M, Cangemi G, Pozzi S, Rigo V, Scaruffi P, Amoroso L, Erminio G, Pistoia V, Ferrini S, Corrias MV.

Oncotarget. 2017 May 30;8(32):53194-53209. doi: 10.18632/oncotarget.18285. eCollection 2017 Aug 8.

11.

State of the art on oocyte cryopreservation in female cancer patients: A critical review of the literature.

Massarotti C, Scaruffi P, Lambertini M, Remorgida V, Del Mastro L, Anserini P.

Cancer Treat Rev. 2017 Jun;57:50-57. doi: 10.1016/j.ctrv.2017.04.009. Epub 2017 May 9. Review.

PMID:
28550713
12.

Multi-omic profiling of MYCN-amplified neuroblastoma cell-lines.

Dassi E, Greco V, Sidarovich V, Zuccotti P, Arseni N, Scaruffi P, Tonini GP, Quattrone A.

Genom Data. 2015 Nov 11;6:285-7. doi: 10.1016/j.gdata.2015.11.012. eCollection 2015 Dec.

13.

Translational compensation of genomic instability in neuroblastoma.

Dassi E, Greco V, Sidarovich V, Zuccotti P, Arseni N, Scaruffi P, Tonini GP, Quattrone A.

Sci Rep. 2015 Sep 24;5:14364. doi: 10.1038/srep14364.

14.

Storage time does not modify the gene expression profile of cryopreserved human metaphase II oocytes.

Stigliani S, Moretti S, Anserini P, Casciano I, Venturini PL, Scaruffi P.

Hum Reprod. 2015 Nov;30(11):2519-26. doi: 10.1093/humrep/dev232. Epub 2015 Sep 18.

PMID:
26385790
15.

Expression of FOXP3, CD14, and ARG1 in Neuroblastoma Tumor Tissue from High-Risk Patients Predicts Event-Free and Overall Survival.

Stigliani S, Croce M, Morandi F, Scaruffi P, Rigo V, Carlini B, Manzitti C, Gigliotti AR, Tonini GP, Pistoia V, Ferrini S, Corrias MV.

Biomed Res Int. 2015;2015:347867. doi: 10.1155/2015/347867. Epub 2015 Jun 16.

16.

Deregulation of focal adhesion pathway mediated by miR-659-3p is implicated in bone marrow infiltration of stage M neuroblastoma patients.

Stigliani S, Scaruffi P, Lagazio C, Persico L, Carlini B, Varesio L, Morandi F, Morini M, Gigliotti AR, Esposito MR, Viscardi E, Cecinati V, Conte M, Corrias MV.

Oncotarget. 2015 May 30;6(15):13295-308.

17.

Mitochondrial DNA in Day 3 embryo culture medium is a novel, non-invasive biomarker of blastocyst potential and implantation outcome.

Stigliani S, Persico L, Lagazio C, Anserini P, Venturini PL, Scaruffi P.

Mol Hum Reprod. 2014 Dec;20(12):1238-46. doi: 10.1093/molehr/gau086. Epub 2014 Sep 17.

PMID:
25232043
18.

Revised risk estimation and treatment stratification of low- and intermediate-risk neuroblastoma patients by integrating clinical and molecular prognostic markers.

Oberthuer A, Juraeva D, Hero B, Volland R, Sterz C, Schmidt R, Faldum A, Kahlert Y, Engesser A, Asgharzadeh S, Seeger R, Ohira M, Nakagawara A, Scaruffi P, Tonini GP, Janoueix-Lerosey I, Delattre O, Schleiermacher G, Vandesompele J, Speleman F, Noguera R, Piqueras M, Bénard J, Valent A, Avigad S, Yaniv I, Grundy RG, Ortmann M, Shao C, Schwab M, Eils R, Simon T, Theissen J, Berthold F, Westermann F, Brors B, Fischer M.

Clin Cancer Res. 2015 Apr 15;21(8):1904-15. doi: 10.1158/1078-0432.CCR-14-0817. Epub 2014 Sep 17.

19.

Mitochondrial DNA content in embryo culture medium is significantly associated with human embryo fragmentation.

Stigliani S, Anserini P, Venturini PL, Scaruffi P.

Hum Reprod. 2013 Oct;28(10):2652-60. doi: 10.1093/humrep/det314. Epub 2013 Jul 25.

PMID:
23887072
20.

High genomic instability predicts survival in metastatic high-risk neuroblastoma.

Stigliani S, Coco S, Moretti S, Oberthuer A, Fischer M, Theissen J, Gallo F, Garavent A, Berthold F, Bonassi S, Tonini GP, Scaruffi P.

Neoplasia. 2012 Sep;14(9):823-32.

21.

Segmental chromosome aberrations converge on overexpression of mitotic spindle regulatory genes in high-risk neuroblastoma.

Ooi WF, Re A, Sidarovich V, Canella V, Arseni N, Adami V, Guarguaglini G, Giubettini M, Scaruffi P, Stigliani S, Lavia P, Tonini GP, Quattrone A.

Genes Chromosomes Cancer. 2012 Jun;51(6):545-56. doi: 10.1002/gcc.21940. Epub 2012 Feb 15.

PMID:
22337647
22.

Bone marrow-infiltrating human neuroblastoma cells express high levels of calprotectin and HLA-G proteins.

Morandi F, Scaruffi P, Gallo F, Stigliani S, Moretti S, Bonassi S, Gambini C, Mazzocco K, Fardin P, Haupt R, Arcamone G; Italian Cooperative Group for Neuroblastoma, Pistoia V, Tonini GP, Corrias MV.

PLoS One. 2012;7(1):e29922. doi: 10.1371/journal.pone.0029922. Epub 2012 Jan 9.

23.

Age-dependent accumulation of genomic aberrations and deregulation of cell cycle and telomerase genes in metastatic neuroblastoma.

Coco S, Theissen J, Scaruffi P, Stigliani S, Moretti S, Oberthuer A, Valdora F, Fischer M, Gallo F, Hero B, Bonassi S, Berthold F, Tonini GP.

Int J Cancer. 2012 Oct 1;131(7):1591-600. doi: 10.1002/ijc.27432. Epub 2012 Feb 18.

24.

Genomic aberrations in normal appearing mucosa fields distal from oral potentially malignant lesions.

Giaretti W, Maffei M, Pentenero M, Scaruffi P, Donadini A, Di Nallo E, Malacarne D, Marino R, Familiari U, Coco S, Tonini GP, Castagnola P, Gandolfo S.

Cell Oncol (Dordr). 2012 Feb;35(1):43-52. doi: 10.1007/s13402-011-0064-2. Epub 2011 Dec 6.

25.

Chromosomal aberrations and aneuploidy in oral potentially malignant lesions: distinctive features for tongue.

Castagnola P, Malacarne D, Scaruffi P, Maffei M, Donadini A, Di Nallo E, Coco S, Tonini GP, Pentenero M, Gandolfo S, Giaretti W.

BMC Cancer. 2011 Oct 13;11:445. doi: 10.1186/1471-2407-11-445.

26.

Bone marrow of neuroblastoma patients shows downregulation of CXCL12 expression and presence of IFN signature.

Scaruffi P, Morandi F, Gallo F, Stigliani S, Parodi S, Moretti S, Bonassi S, Fardin P, Garaventa A, Zanazzo G, Pistoia V, Tonini GP, Corrias MV.

Pediatr Blood Cancer. 2012 Jul 15;59(1):44-51. doi: 10.1002/pbc.23339. Epub 2011 Oct 12.

PMID:
21994039
27.

Serum levels of cytoplasmic melanoma-associated antigen at diagnosis may predict clinical relapse in neuroblastoma patients.

Morandi F, Corrias MV, Levreri I, Scaruffi P, Raffaghello L, Carlini B, Bocca P, Prigione I, Stigliani S, Amoroso L, Ferrone S, Pistoia V.

Cancer Immunol Immunother. 2011 Oct;60(10):1485-95. doi: 10.1007/s00262-011-1052-0. Epub 2011 Jun 10.

28.

Role of CXCL13-CXCR5 crosstalk between malignant neuroblastoma cells and Schwannian stromal cells in neuroblastic tumors.

Del Grosso F, Coco S, Scaruffi P, Stigliani S, Valdora F, Benelli R, Salvi S, Boccardo S, Truini M, Croce M, Ferrini S, Longo L, Tonini GP.

Mol Cancer Res. 2011 Jul;9(7):815-23. doi: 10.1158/1541-7786.MCR-10-0367. Epub 2011 Jun 3.

29.

Gene expression profiling identifies eleven DNA repair genes down-regulated during mouse neural crest cell migration.

Albino D, Brizzolara A, Moretti S, Falugi C, Mirisola V, Scaruffi P, Di Candia M, Truini M, Coco S, Bonassi S, Tonini GP.

Int J Dev Biol. 2011;55(1):65-72. doi: 10.1387/ijdb.092970da.

30.

Chromosome 9q and 16q loss identified by genome-wide pooled-analysis are associated with tumor aggressiveness in patients with classic medulloblastoma.

Coco S, Valdora F, Bonassi S, Scaruffi P, Stigliani S, Oberthuer A, Berthold F, Andolfo I, Servidei T, Riccardi R, Basso E, Iolascon A, Tonini GP.

OMICS. 2011 May;15(5):273-80. doi: 10.1089/omi.2010.0103. Epub 2011 Feb 24.

PMID:
21348762
31.

Electrical characterization of DNA-functionalized solid state nanopores for bio-sensing.

Mussi V, Fanzio P, Repetto L, Firpo G, Scaruffi P, Stigliani S, Menotta M, Magnani M, Tonini GP, Valbusa U.

J Phys Condens Matter. 2010 Nov 17;22(45):454104. doi: 10.1088/0953-8984/22/45/454104. Epub 2010 Oct 29.

PMID:
21339592
32.

Constitutional change of Italian legislation on assisted reproduction technology improves pregnancy rate especially in older patients.

Scaruffi P, Primavera MR, Abbamonte LH, Levi S, De Leo C, Nicoletti A, Anserini P.

Hum Reprod. 2011 Apr;26(4):959-61. doi: 10.1093/humrep/der014. Epub 2011 Feb 11. No abstract available.

PMID:
21317151
33.

The transcribed-ultraconserved regions: a novel class of long noncoding RNAs involved in cancer susceptibility.

Scaruffi P.

ScientificWorldJournal. 2011 Feb 3;11:340-52. doi: 10.1100/tsw.2011.35. Review.

34.

A novel splice variant of the human dicer gene is expressed in neuroblastoma cells.

Potenza N, Papa U, Scaruffi P, Mosca N, Tonini GP, Russo A.

FEBS Lett. 2010 Aug 4;584(15):3452-7. doi: 10.1016/j.febslet.2010.06.045. Epub 2010 Jul 6.

35.

Prognostic impact of gene expression-based classification for neuroblastoma.

Oberthuer A, Hero B, Berthold F, Juraeva D, Faldum A, Kahlert Y, Asgharzadeh S, Seeger R, Scaruffi P, Tonini GP, Janoueix-Lerosey I, Delattre O, Schleiermacher G, Vandesompele J, Vermeulen J, Speleman F, Noguera R, Piqueras M, Bénard J, Valent A, Avigad S, Yaniv I, Weber A, Christiansen H, Grundy RG, Schardt K, Schwab M, Eils R, Warnat P, Kaderali L, Simon T, Decarolis B, Theissen J, Westermann F, Brors B, Fischer M.

J Clin Oncol. 2010 Jul 20;28(21):3506-15. doi: 10.1200/JCO.2009.27.3367. Epub 2010 Jun 21.

PMID:
20567016
36.

Detection of cell-free RNA in children with neuroblastoma and comparison with that of whole blood cell RNA.

Corrias MV, Pistorio A, Cangemi G, Tripodi G, Carlini B, Scaruffi P, Fardin P, Garaventa A, Pistoia V, Haupt R.

Pediatr Blood Cancer. 2010 Jul 1;54(7):897-903. doi: 10.1002/pbc.22498.

PMID:
20405510
37.

DNA-functionalized solid state nanopore for biosensing.

Mussi V, Fanzio P, Repetto L, Firpo G, Scaruffi P, Stigliani S, Tonini GP, Valbusa U.

Nanotechnology. 2010 Apr 9;21(14):145102. doi: 10.1088/0957-4484/21/14/145102. Epub 2010 Mar 11.

PMID:
20220223
38.

Transcribed-ultra conserved region expression profiling from low-input total RNA.

Scaruffi P, Stigliani S, Coco S, Valdora F, De Vecchi C, Bonassi S, Tonini GP.

BMC Genomics. 2010 Mar 3;11:149. doi: 10.1186/1471-2164-11-149.

39.

Transcribed-Ultra Conserved Region expression is associated with outcome in high-risk neuroblastoma.

Scaruffi P, Stigliani S, Moretti S, Coco S, De Vecchi C, Valdora F, Garaventa A, Bonassi S, Tonini GP.

BMC Cancer. 2009 Dec 15;9:441. doi: 10.1186/1471-2407-9-441.

40.

c.1810C>T polymorphism of NTRK1 gene is associated with reduced survival in neuroblastoma patients.

Lipska BS, Drozynska E, Scaruffi P, Tonini GP, Izycka-Swieszewska E, Zietkiewicz S, Balcerska A, Perek D, Chybicka A, Biernat W, Limon J.

BMC Cancer. 2009 Dec 13;9:436. doi: 10.1186/1471-2407-9-436.

41.

Risk of malignant pleural mesothelioma and polymorphisms in genes involved in the genome stability and xenobiotics metabolism.

Gemignani F, Neri M, Bottari F, Barale R, Canessa PA, Canzian F, Ceppi M, Spitaleri I, Cipollini M, Ivaldi GP, Mencoboni M, Scaruffi P, Tonini GP, Ugolini D, Mutti L, Bonassi S, Landi S.

Mutat Res. 2009 Dec 1;671(1-2):76-83. doi: 10.1016/j.mrfmmm.2009.09.003. Epub 2009 Sep 12.

PMID:
19751749
42.

Outcome prediction and risk assessment by quantitative pyrosequencing methylation analysis of the SFN gene in advanced stage, high-risk, neuroblastic tumor patients.

Banelli B, Bonassi S, Casciano I, Mazzocco K, Di Vinci A, Scaruffi P, Brigati C, Allemanni G, Borzì L, Tonini GP, Romani M.

Int J Cancer. 2010 Feb 1;126(3):656-68. doi: 10.1002/ijc.24768.

43.

Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study.

Vermeulen J, De Preter K, Naranjo A, Vercruysse L, Van Roy N, Hellemans J, Swerts K, Bravo S, Scaruffi P, Tonini GP, De Bernardi B, Noguera R, Piqueras M, Cañete A, Castel V, Janoueix-Lerosey I, Delattre O, Schleiermacher G, Michon J, Combaret V, Fischer M, Oberthuer A, Ambros PF, Beiske K, Bénard J, Marques B, Rubie H, Kohler J, Pötschger U, Ladenstein R, Hogarty MD, McGrady P, London WB, Laureys G, Speleman F, Vandesompele J.

Lancet Oncol. 2009 Jul;10(7):663-71. doi: 10.1016/S1470-2045(09)70154-8. Epub 2009 Jun 8.

44.

Genome and transcriptome analysis of neuroblastoma advanced diagnosis from innovative therapies.

Coco S, Tonini GP, Stigliani S, Scaruffi P.

Curr Pharm Des. 2009;15(4):448-55. Review.

PMID:
19199972
45.

Identification of low intratumoral gene expression heterogeneity in neuroblastic tumors by genome-wide expression analysis and game theory.

Albino D, Scaruffi P, Moretti S, Coco S, Truini M, Di Cristofano C, Cavazzana A, Stigliani S, Bonassi S, Tonini GP.

Cancer. 2008 Sep 15;113(6):1412-22. doi: 10.1002/cncr.23720.

46.

Identification and characterization of DNA imbalances in neuroblastoma by high-resolution oligonucleotide array comparative genomic hybridization.

Scaruffi P, Coco S, Cifuentes F, Albino D, Nair M, Defferrari R, Mazzocco K, Tonini GP.

Cancer Genet Cytogenet. 2007 Aug;177(1):20-9.

PMID:
17693187
47.

Polymorphisms of glutathione-S-transferase M1 and manganese superoxide dismutase are associated with the risk of malignant pleural mesothelioma.

Landi S, Gemignani F, Neri M, Barale R, Bonassi S, Bottari F, Canessa PA, Canzian F, Ceppi M, Filiberti R, Ivaldi GP, Mencoboni M, Scaruffi P, Tonini GP, Mutti L, Puntoni R.

Int J Cancer. 2007 Jun 15;120(12):2739-43.

48.

Oligonucleotide Array Comparative Genomic Hybridization Profiling of Neuroblastoma Tumours.

Scaruffi P, Moretti S, Coco S, Mazzocco K, Defferrari R, Albino D, Bonassi S, Tonini GP.

Cancer Genomics Proteomics. 2006 May-Aug;3(3-4):245-252. Epub 2006 Jan 1.

49.

Genome analysis and gene expression profiling of neuroblastoma and ganglioneuroblastoma reveal differences between neuroblastic and Schwannian stromal cells.

Coco S, Defferrari R, Scaruffi P, Cavazzana A, Di Cristofano C, Longo L, Mazzocco K, Perri P, Gambini C, Moretti S, Bonassi S, Tonini GP.

J Pathol. 2005 Nov;207(3):346-57.

PMID:
16178058
50.

Distinct CpG methylation profiles characterize different clinical groups of neuroblastic tumors.

Banelli B, Gelvi I, Di Vinci A, Scaruffi P, Casciano I, Allemanni G, Bonassi S, Tonini GP, Romani M.

Oncogene. 2005 Aug 25;24(36):5619-28.

PMID:
16044164

Supplemental Content

Loading ...
Support Center